![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
FOSTEMSAVIR EXPOSURE-RESPONSE RELATIONSHIPS IN TREATMENT EXPERIENCED HIV PATIENTS
|
|
|
CROI 2020 March 8-11
Reported by Jules Levin
Ridhi Parasrampuria,1Navin Goyal,1Katy Moore,2Peter Ackerman,3Cyril C. Llamoso,3Keith Barker,4Mindy Magee1
1GlaxoSmithKline, Collegeville, PA, USA; 2ViiV Healthcare, Research Triangle Park, NC, USA; 3ViiV Healthcare, Branford, CT, USA; 4GlaxoSmithKline, Uxbridge, UK
![0316201](../images/031620/031620-3/0316201.gif)
![0316202](../images/031620/031620-3/0316202.gif)
![0316203](../images/031620/031620-3/0316203.gif)
![0316204](../images/031620/031620-3/0316204.gif)
![0316205](../images/031620/031620-3/0316205.gif)
![0316206](../images/031620/031620-3/0316206.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|